Related Experiment Videos
Initial human evaluation of argon laser-assisted vascular anastomoses
R A White1, G H White, R M Fujitani
1Division of Vascular Surgery, Harbor-UCLA Medical Center, Torrance 90509.
Journal of Vascular Surgery
|April 1, 1989
Summary
Argon laser vascular tissue fusion shows promise for creating Brescia-Cimino arteriovenous fistulas in patients with chronic renal failure. Preliminary results indicate successful, durable anastomoses with no aneurysms during long-term follow-up.
Area of Science:
- Vascular Surgery
- Medical Laser Applications
- Nephrology
Background:
- Brescia-Cimino arteriovenous fistulas are crucial for hemodialysis access in patients with chronic renal failure.
- Traditional surgical anastomosis techniques carry risks of complications.
Purpose of the Study:
- To evaluate the feasibility and safety of argon laser-assisted vascular tissue fusion for creating arteriovenous fistulas in humans.
- To assess the long-term patency and integrity of laser-fused anastomoses.
Main Methods:
- Forearm Brescia-Cimino arteriovenous fistulas were created in ten patients using argon laser energy for tissue fusion.
- Four sutures divided the anastomosis into segments, which were then sealed with laser energy.
- Patients underwent serial follow-up including physical examination and duplex scanning for up to 20 months.
Main Results:
- Laser-assisted fusion successfully sealed vascular anastomoses in 75-100 seconds per segment.
- A small percentage (17.5%) of anastomoses required supplementary sutures for minor gaps.
- Follow-up demonstrated uniformly patent and compliant fistulas with no hematomas, aneurysms, or narrowing.
- Histologic examination confirmed successful healing of the anastomoses.
Conclusions:
- Argon laser vascular tissue fusion is a viable technique for human arteriovenous fistula creation.
- The laser-assisted method results in durable, complication-free anastomoses with excellent healing characteristics.
- This technique holds potential for improving vascular access procedures in patients requiring chronic hemodialysis.